CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. 4D RT
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. LINAC
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. MRI-guided Radiotherapy
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Portal Imaging
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. CT Scanning
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
CHAPTER 5: IMAGE-GUIDED RADIATION THERAPY MARKET, BY PROCEDURE
5.1. Market Overview
5.1.1 Market Size and Forecast, By Procedure
5.2. IMRT (intensity Modulation Radiation Therapy)
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Stereotactic Therapy
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Particle Therapy
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: IMAGE-GUIDED RADIATION THERAPY MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Independent Radiotherapy Centers
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Procedure
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Image-Guided Radiation Therapy Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Procedure
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Image-Guided Radiation Therapy Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Procedure
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Image-Guided Radiation Therapy Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Procedure
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Procedure
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Image-Guided Radiation Therapy Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Procedure
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Image-Guided Radiation Therapy Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Procedure
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Image-Guided Radiation Therapy Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Procedure
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Image-Guided Radiation Therapy Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Procedure
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Image-Guided Radiation Therapy Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Procedure
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Image-Guided Radiation Therapy Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Procedure
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Procedure
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Image-Guided Radiation Therapy Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Procedure
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Image-Guided Radiation Therapy Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Procedure
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Image-Guided Radiation Therapy Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Procedure
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Image-Guided Radiation Therapy Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Procedure
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Image-Guided Radiation Therapy Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Procedure
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Image-Guided Radiation Therapy Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Procedure
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Procedure
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Image-Guided Radiation Therapy Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Procedure
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Image-Guided Radiation Therapy Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Procedure
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Image-Guided Radiation Therapy Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Procedure
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Image-Guided Radiation Therapy Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Procedure
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Varian Medical Systems, Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Elekta AB, Accuray Incorporated
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. ViewRay, Inc.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Siemens Healthineers AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Hitachi, Ltd
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Brainlab AG
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. MEVION MEDICAL SYSTEMS, INC.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. C-Rad AB
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Sumitomo Heavy Industries, Ltd.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Philips Healthcare
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. IMAGE-GUIDED RADIATION THERAPY MARKET FOR 4D RT, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. IMAGE-GUIDED RADIATION THERAPY MARKET FOR LINAC, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. IMAGE-GUIDED RADIATION THERAPY MARKET FOR MRI-GUIDED RADIOTHERAPY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. IMAGE-GUIDED RADIATION THERAPY MARKET FOR PORTAL IMAGING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. IMAGE-GUIDED RADIATION THERAPY MARKET FOR CT SCANNING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 8. IMAGE-GUIDED RADIATION THERAPY MARKET FOR IMRT (INTENSITY MODULATION RADIATION THERAPY), BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. IMAGE-GUIDED RADIATION THERAPY MARKET FOR STEREOTACTIC THERAPY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. IMAGE-GUIDED RADIATION THERAPY MARKET FOR PARTICLE THERAPY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. IMAGE-GUIDED RADIATION THERAPY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 13. IMAGE-GUIDED RADIATION THERAPY MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. IMAGE-GUIDED RADIATION THERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. IMAGE-GUIDED RADIATION THERAPY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. IMAGE-GUIDED RADIATION THERAPY MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 17. NORTH AMERICA IMAGE-GUIDED RADIATION THERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 18. NORTH AMERICA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 19. NORTH AMERICA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 20. NORTH AMERICA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. U.S. IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 22. U.S. IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 23. U.S. IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 24. CANADA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 25. CANADA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 26. CANADA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 27. MEXICO IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 28. MEXICO IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 29. MEXICO IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. EUROPE IMAGE-GUIDED RADIATION THERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 31. EUROPE IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 32. EUROPE IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 33. EUROPE IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. FRANCE IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 35. FRANCE IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 36. FRANCE IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. GERMANY IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 38. GERMANY IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 39. GERMANY IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 40. ITALY IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 41. ITALY IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 42. ITALY IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. SPAIN IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 44. SPAIN IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 45. SPAIN IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. UK IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 47. UK IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 48. UK IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. REST OF EUROPE IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 50. REST OF EUROPE IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 51. REST OF EUROPE IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 52. ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 53. ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 54. ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 55. ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. CHINA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 57. CHINA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 58. CHINA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 59. JAPAN IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 60. JAPAN IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 61. JAPAN IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. INDIA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 63. INDIA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 64. INDIA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 65. SOUTH KOREA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 66. SOUTH KOREA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 67. SOUTH KOREA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 68. AUSTRALIA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 69. AUSTRALIA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 70. AUSTRALIA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 71. REST OF ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 72. REST OF ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 73. REST OF ASIA-PACIFIC IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 74. LAMEA IMAGE-GUIDED RADIATION THERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 75. LAMEA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 76. LAMEA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 77. LAMEA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 78. BRAZIL IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 79. BRAZIL IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 80. BRAZIL IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 81. SOUTH AFRICA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 82. SOUTH AFRICA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 83. SOUTH AFRICA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 84. SAUDI ARABIA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 85. SAUDI ARABIA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 86. SAUDI ARABIA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 87. REST OF LAMEA IMAGE-GUIDED RADIATION THERAPY, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 88. REST OF LAMEA IMAGE-GUIDED RADIATION THERAPY, BY PROCEDURE, 2024 - 2033 ($BILLION)
TABLE 89. REST OF LAMEA IMAGE-GUIDED RADIATION THERAPY, BY END USER, 2024 - 2033 ($BILLION)
TABLE 90. VARIAN MEDICAL SYSTEMS, INC.: KEY EXECUTIVES
TABLE 91. VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
TABLE 92. VARIAN MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
TABLE 93. VARIAN MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
TABLE 94. VARIAN MEDICAL SYSTEMS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95. ELEKTA AB, ACCURAY INCORPORATED: KEY EXECUTIVES
TABLE 96. ELEKTA AB, ACCURAY INCORPORATED: COMPANY SNAPSHOT
TABLE 97. ELEKTA AB, ACCURAY INCORPORATED: OPERATING SEGMENTS
TABLE 98. ELEKTA AB, ACCURAY INCORPORATED: PRODUCT PORTFOLIO
TABLE 99. ELEKTA AB, ACCURAY INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. VIEWRAY, INC.: KEY EXECUTIVES
TABLE 101. VIEWRAY, INC.: COMPANY SNAPSHOT
TABLE 102. VIEWRAY, INC.: OPERATING SEGMENTS
TABLE 103. VIEWRAY, INC.: PRODUCT PORTFOLIO
TABLE 104. VIEWRAY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 105. SIEMENS HEALTHINEERS AG: KEY EXECUTIVES
TABLE 106. SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
TABLE 107. SIEMENS HEALTHINEERS AG: OPERATING SEGMENTS
TABLE 108. SIEMENS HEALTHINEERS AG: PRODUCT PORTFOLIO
TABLE 109. SIEMENS HEALTHINEERS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 110. HITACHI, LTD: KEY EXECUTIVES
TABLE 111. HITACHI, LTD: COMPANY SNAPSHOT
TABLE 112. HITACHI, LTD: OPERATING SEGMENTS
TABLE 113. HITACHI, LTD: PRODUCT PORTFOLIO
TABLE 114. HITACHI, LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115. BRAINLAB AG: KEY EXECUTIVES
TABLE 116. BRAINLAB AG: COMPANY SNAPSHOT
TABLE 117. BRAINLAB AG: OPERATING SEGMENTS
TABLE 118. BRAINLAB AG: PRODUCT PORTFOLIO
TABLE 119. BRAINLAB AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 120. MEVION MEDICAL SYSTEMS, INC.: KEY EXECUTIVES
TABLE 121. MEVION MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
TABLE 122. MEVION MEDICAL SYSTEMS, INC.: OPERATING SEGMENTS
TABLE 123. MEVION MEDICAL SYSTEMS, INC.: PRODUCT PORTFOLIO
TABLE 124. MEVION MEDICAL SYSTEMS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 125. C-RAD AB: KEY EXECUTIVES
TABLE 126. C-RAD AB: COMPANY SNAPSHOT
TABLE 127. C-RAD AB: OPERATING SEGMENTS
TABLE 128. C-RAD AB: PRODUCT PORTFOLIO
TABLE 129. C-RAD AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. SUMITOMO HEAVY INDUSTRIES, LTD.: KEY EXECUTIVES
TABLE 131. SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY SNAPSHOT
TABLE 132. SUMITOMO HEAVY INDUSTRIES, LTD.: OPERATING SEGMENTS
TABLE 133. SUMITOMO HEAVY INDUSTRIES, LTD.: PRODUCT PORTFOLIO
TABLE 134. SUMITOMO HEAVY INDUSTRIES, LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 135. PHILIPS HEALTHCARE: KEY EXECUTIVES
TABLE 136. PHILIPS HEALTHCARE: COMPANY SNAPSHOT
TABLE 137. PHILIPS HEALTHCARE: OPERATING SEGMENTS
TABLE 138. PHILIPS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 139. PHILIPS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SEGMENTATION
FIGURE 2. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET
FIGURE 3. SEGMENTATION IMAGE-GUIDED RADIATION THERAPY MARKET
FIGURE 4. TOP INVESTMENT POCKET IN IMAGE-GUIDED RADIATION THERAPY MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALIMAGE-GUIDED RADIATION THERAPY MARKET
FIGURE 11. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SEGMENTATION, BY PRODUCT
FIGURE 12. IMAGE-GUIDED RADIATION THERAPY MARKET FOR 4D RT, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. IMAGE-GUIDED RADIATION THERAPY MARKET FOR LINAC, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. IMAGE-GUIDED RADIATION THERAPY MARKET FOR MRI-GUIDED RADIOTHERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. IMAGE-GUIDED RADIATION THERAPY MARKET FOR PORTAL IMAGING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. IMAGE-GUIDED RADIATION THERAPY MARKET FOR CT SCANNING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SEGMENTATION, BY PROCEDURE
FIGURE 18. IMAGE-GUIDED RADIATION THERAPY MARKET FOR IMRT (INTENSITY MODULATION RADIATION THERAPY), BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. IMAGE-GUIDED RADIATION THERAPY MARKET FOR STEREOTACTIC THERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. IMAGE-GUIDED RADIATION THERAPY MARKET FOR PARTICLE THERAPY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. IMAGE-GUIDED RADIATION THERAPY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. GLOBAL IMAGE-GUIDED RADIATION THERAPY MARKET SEGMENTATION, BY END USER
FIGURE 23. IMAGE-GUIDED RADIATION THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. IMAGE-GUIDED RADIATION THERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 25. IMAGE-GUIDED RADIATION THERAPY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 30. COMPETITIVE DASHBOARD
FIGURE 31. COMPETITIVE HEATMAP: IMAGE-GUIDED RADIATION THERAPY MARKET
FIGURE 32. TOP PLAYER POSITIONING, 2023
FIGURE 33. VARIAN MEDICAL SYSTEMS, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. VARIAN MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. VARIAN MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. ELEKTA AB, ACCURAY INCORPORATED: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. ELEKTA AB, ACCURAY INCORPORATED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. ELEKTA AB, ACCURAY INCORPORATED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. VIEWRAY, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. VIEWRAY, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. VIEWRAY, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. SIEMENS HEALTHINEERS AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. SIEMENS HEALTHINEERS AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. SIEMENS HEALTHINEERS AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. HITACHI, LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. HITACHI, LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. HITACHI, LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. BRAINLAB AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. BRAINLAB AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. BRAINLAB AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. MEVION MEDICAL SYSTEMS, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. MEVION MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. MEVION MEDICAL SYSTEMS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. C-RAD AB: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. C-RAD AB: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. C-RAD AB: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 57. SUMITOMO HEAVY INDUSTRIES, LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 58. SUMITOMO HEAVY INDUSTRIES, LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 59. SUMITOMO HEAVY INDUSTRIES, LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 60. PHILIPS HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 61. PHILIPS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 62. PHILIPS HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
